Welcome to our dedicated page for TrueBlue SEC filings (Ticker: TBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TrueBlue, Inc. filings document the public-company disclosures of a specialized workforce solutions provider whose common stock trades on the New York Stock Exchange under TBI. Its Form 8-K reports cover quarterly results, Regulation FD materials, material agreements, financing arrangements, executive appointments and governance-related communications.
TrueBlue proxy and related filings describe annual meeting matters, board governance, compensation and shareholder voting procedures. Recent filings also document amendments to the company’s credit agreement, stockholder rights arrangements, the expiration and withdrawal from listing of preferred stock purchase rights, and solicitation materials connected to shareholder engagement and board matters.
TrueBlue, Inc. director Kristi A. Savacool reported an equity award of 27,566 shares of Common Stock, received as a grant of restricted stock units at no cash cost to her. These units will convert into shares on a one-for-one basis.
The restricted stock units vest in full one year from the grant date, with delivery of the vested shares scheduled 90 days after her separation from service on the Board. Following this award, she reports direct beneficial ownership of 89,536 shares, including 82,940 shares deferred under the company’s director compensation plan.
Kreidler Robert C. reported acquisition or exercise transactions in this Form 4 filing.
TrueBlue, Inc. director Robert C. Kreidler reported an equity award of 27,566 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis in common shares.
Delivery of the vested shares to Kreidler will occur 90 days after his separation from service on the Board of Directors. Following this award, his directly held and deferred holdings total 85,381 shares, including 71,664 shares deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.
Jones Kim Harris reported acquisition or exercise transactions in this Form 4 filing.
TrueBlue, Inc. director Kim Harris Jones reported an equity award of 29,607 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis into common shares.
After this grant, her directly held and deferred holdings total 100,060 shares, including 94,719 shares deferred under TrueBlue’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Vested shares from this award will be delivered 90 days after her separation from the Board.
TrueBlue, Inc. director Colleen B. Brown reported an equity award of 29,097 shares of Common Stock at a stated price of $0.00 per share. A footnote explains this represents a grant of restricted stock units that will convert into shares on a one-for-one basis and vest in full one year from the grant date. Following this award, her directly held Common Stock balance is 89,112 shares.
TrueBlue, Inc. outlines its role as a specialized workforce solutions provider and key risks facing the business. In fiscal 2025, the company connected approximately 291,000 people with work and served about 53,000 clients across construction, logistics, retail, hospitality, healthcare and other sectors.
Operations are organized into three segments: PeopleReady for on-demand and skilled trades staffing, PeopleManagement for on‑site industrial and driver solutions, and PeopleSolutions for recruitment process outsourcing, managed service provider programs and healthcare staffing. Strategy for fiscal 2026 focuses on strengthening sales, expanding in high‑growth and less cyclical end markets (including healthcare and skilled trades), and accelerating technology such as JobStack, Stafftrack and the Affinix platform.
The filing highlights extensive risk factors, including economic cyclicality, technology disruption and AI, workers’ compensation costs, client concentration, integration of acquisitions such as Healthcare Staffing Professionals, Inc., regulatory and tax changes, cybersecurity and data privacy exposures, and the need to attract and retain employees and contingent associates.
TrueBlue, Inc. reported fourth-quarter 2025 revenue of $418 million, an 8% increase driven by 5% organic growth and contributions from the HSP acquisition. Despite higher sales, the company posted a net loss of $31.5 million, widened by an $18.4 million non-cash impairment tied to a Chicago support center sublease and lower gross margin from reduced workers’ compensation benefits and mix shifts toward renewable energy work.
Adjusted EBITDA was $2.4 million versus $8.9 million a year earlier, while SG&A fell 11% to $95 million as cost actions took hold. For full-year 2025, revenue reached $1.616 billion, up 3%, with net loss improving to $48.0 million from $125.7 million and adjusted net loss at $20.4 million. The company ended the year with $25 million in cash, $66 million of debt, total liquidity of $92 million, and increased borrowing capacity following a credit facility amendment. Management guided first-quarter 2026 revenue to $381–$406 million, expecting gross margin pressure from prior-year reserve benefits not repeating but further SG&A reductions.
Charles Schwab Investment Management Inc. filed an amended Schedule 13G reporting a passive ownership stake in TrueBlue, Inc. common stock. It reports beneficial ownership of 2,012,217 shares, representing 6.72% of the class as of 12/31/2025.
The firm has sole voting and sole dispositive power over all reported shares, with no shared voting or dispositive authority. It certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of TrueBlue.
TrueBlue, Inc. executive Richard P. Betori, EVP and President of PeopleScout, reported a small stock disposition on a Form 4. On February 4, 2026, he disposed of 379 shares of TrueBlue common stock at $5.51 per share under transaction code F.
Following this transaction, Betori directly beneficially owns 101,401 shares of TrueBlue common stock. The filing reflects a single, non-derivative transaction and shows no derivative securities activity.
TrueBlue, Inc. CEO and President Taryn R. Owen, who also serves as a director, reported an insider equity transaction dated February 3, 2026 involving 5,250 shares of common stock at $5.50 per share, leaving her with 403,259 shares beneficially owned directly.
A footnote explains that her reported beneficial ownership was also reduced by 2,515 shares due to an administrative correction to the number of shares previously withheld to cover tax obligations for five vesting events reported on filings dated February 7, 2023 and February 9, 2023.
TrueBlue, Inc. executive Richard P. Betori reported a small share disposition. On February 3, 2026, he disposed of 515 shares of Common Stock at $5.50 per share under transaction code F. After this transaction, he directly beneficially owned 101,780 Common Stock shares.